PMV Pharmaceuticals, Inc.

In the quarter to June 2026, EPS grew 17.1% and free cash flow grew 20.3%, each against the same quarter a year earlier.

1.21 0.08 −6.20%

Follow PMVP

Alert me

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(70.93%)	(63.16%)	(55.37%)	(51.87%)	+8 more TTM periods Free account
ROA Full definition →	(64.04%)	(58.65%)	(50.51%)	(46.29%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(105.95%)	(89.65%)	(74.72%)	(68.69%)
Free Cash Flow per Share Full definition →	(1.33)	(1.41)	(1.40)	(1.37)
Free Cash Flow Full definition →	(71.26)	(74.99)	(73.57)	(72.87)
Capital Expenditures Full definition →	—	—	0.00	0.18
Other line items
Cash ROIC Full definition →	(47.22%)	(41.31%)	(33.80%)	(29.12%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	(0.03)	(0.03)
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →	0.95	0.96	0.95	0.88
Depreciation/Fixed assets Full definition →	(12.03)	(10.77)	(11.13)	(12.75)
Capex/Depreciation Full definition →	0.00	0.00	0.00	(0.06)
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(1.33)	(1.41)	(1.40)	(1.38)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	—	—	0.00	0.00

Columns are period end dates